Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The new screenshot shows a redesigned layout with updated typography and section spacing, while the core study details (design, primary outcomes, eligibility criteria, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-08T02:16:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant content changes detected in the MIT-E study page between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-31T23:42:34.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    No significant changes detected in the page content; the study description, design, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.2%
    Check dated 2025-12-24T23:15:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with state-level site listings (California, Connecticut, District of Columbia, Maryland, Massachusetts, Minnesota, Ohio, Texas, Washington). The page revision was updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-17T19:04:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The old and new page screenshots show no noticeable changes to the page content or layout.
    Difference
    0.2%
    Check dated 2025-12-10T16:44:08.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The new page shows only layout and styling updates; there are no edits to core study details, eligibility criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-03T12:16:20.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.